Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:MJN

Mead Johnson Nutrition (MJN) Stock Price, News & Analysis

Mead Johnson Nutrition logo

About Mead Johnson Nutrition Stock (NYSE:MJN)

Key Stats

Today's Range
$89.98
$89.98
50-Day Range
N/A
52-Week Range
$69.25
$94.40
Volume
N/A
Average Volume
3.24 million shs
Market Capitalization
N/A
P/E Ratio
24.25
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mead Johnson Nutrition and its competitors with MarketBeat's FREE daily newsletter.

MJN Stock News Headlines

Abbott, Mead Johnson secure win in infant formula trial, Reuters reports
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Reckitt/Mead Johnson Nutrition Recalls Baby Formula Powder
See More Headlines

MJN Stock Analysis - Frequently Asked Questions

Mead Johnson Nutrition CO (NYSE:MJN) announced its quarterly earnings results on Thursday, April, 27th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.01. The firm's revenue was down 8.2% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mead Johnson Nutrition investors own include Bristol-Myers Squibb (BMY), NVIDIA (NVDA), Ford Motor (F), Yum! Brands (YUM), Broadcom (BRCM), Caterpillar (CAT) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
4/27/2017
Today
12/22/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Packaged Foods & Meats
CUSIP
58283910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NYSE:MJN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners